Elsevier

Autoimmunity Reviews

Volume 16, Issue 10, October 2017, Pages 1036-1043
Autoimmunity Reviews

Review
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome

https://doi.org/10.1016/j.autrev.2017.07.020Get rights and content

Highlights

  • ANCA-associated vasculitis and IgG4-related diseases may overlap, mainly in patients with granulomatosis with polyangiitis.

  • IgG4-related diseases manifestations were mainly chronic periaortitis, orbital mass and tubulointerstitial nephritis.

  • Rituximab could be preferentially used in these overlap syndromes to treat both diseases.

Abstract

Objective

Atypical manifestations have been described in patients with ANCA-associated vasculitides (AAV), such as pachymeningitis, orbital mass or chronic periaortitis. Because these manifestations have been associated to the spectrum of IgG4-related disease (IgG4-RD), we hypothesized that both diseases could overlap.

Methods

We conducted a European retrospective multicenter observational study including patients fulfilling ACR and Chapel Hill criteria for AAV and IgG4-RD Comprehensive Diagnostic Criteria.

Results

Eighteen patients were included (median age 55.5 years, 13 men). AAV and IgG4-RD were diagnosed concomitantly in 13/18 (72%) patients; AAV preceded IgG4-RD in 3/18 (17%) while IgG4-RD preceded AAV in 2/18 (11%). AAV diagnoses included granulomatosis with polyangiitis in 14 (78%), microscopic polyangiitis in 3 (17%), and eosinophilic granulomatosis with polyangiitis in one case. IgG4-RD diagnosis included definite IgG4-RD in 5 (28%) cases, probable IgG4-RD in 5 (28%) and possible IgG4-RD in 8 (44%). IgG4-RD manifestations were chronic periaortitis in 9/18 (50%) patients, orbital mass and tubulointerstitial nephritis in 4 (22%) cases, prevertebral fibrosis in 3 (17%), pachymeningitis and autoimmune pancreatitis in 2 (11%) cases. Patients required median number of 2 (range 0–4) lines of immunosuppressants in combination with glucocorticoids. During the follow-up (median 49,8 months, range 17,25–108 months), AAV manifestations relapsed in 10/18 (56%) cases and IgG4-RD lesions in 5/18 (28%). When used, mainly for relapses, rituximab showed response in all cases.

Conclusion

AAV and IgG4-RD may overlap. Clinicians should consider that atypical manifestations during AAV could be related to IgG4-RD rather than to refractory granulomatous or vasculitic lesions.

Introduction

Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides include granulomatosis with polyangiitis (GPA, formerly Wegener's granulomatosis), eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome) and microscopic polyangiitis (MPA) [1]. ANCA are present in the majority of cases during initial presentation, targeting either proteinase-3 (PR3) or myeloperoxidase (MPO) [1]. Although AAV are mainly characterized by manifestations related to necrotizing small-vessel vasculitis, some of them may be related to granulomatous inflammation, particularly in GPA and EGPA [2]. Atypical manifestations may also occur, such as orbital mass or pachymeningitis leading to organ- or life-threatening complications, and they are often characterized by poor response to conventional therapies [3], [4]. Because of their location, histological samples are rarely available, but when biopsies are feasible, histological examination can reveal findings suggestive of vasculitis and/or granulomatous inflammation, and also some fibrosis and/or lymphoplasmacytic infiltration [5].

IgG4-related disease (IgG4-RD) is a fibro-inflammatory disease characterized by inflammatory pseudotumors and histologically by dense lymphoplasmacytic infiltrates rich in IgG4-positive plasma cells, storiform fibrosis and obliterative phlebitis [6]. Since its first identification in 2003, the spectrum of manifestations associated with IgG4-RD has become clearer [7]. Hence, different inflammatory diseases previously considered as idiopathic have been retrospectively included in the spectrum of IgG4-RD, such as a part of retroperitoneal fibrosis and inflammatory aortic aneurysms, Mikulicz's disease, Riedel thyroiditis, orbital inflammatory pseudotumors, tubulointerstitial nephritis, eosinophilic angiocentric fibrosis, or pachymeningitis [8], [9], [10]. Although quite rarely, IgG4-RD was found to be associated with medium or small-vessel vasculitides, in which histological description of vasculitis was associated with lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells [11], [12]. Furthermore, IgG4-positive plasma cell infiltrates and high serum IgG4 levels have been described in various conditions, such as EGPA and other eosinophilic disorders, Rosai-Dorfman disease or multicentric Castleman's disease [13], [14].

To puzzle out this potential overlap syndrome, we conducted a European multicenter observational study including patients presenting with both AAV and IgG4-RD.

Section snippets

Patients

We performed a European multicenter survey on behalf of the French Vasculitis Study Group (FVSG) among specialized vasculitis centers in Europe (mainly including departments of Internal Medicine, Rheumatology and Nephrology from Austria, Belgium, Italy and France), in order to identify patients who met AAV and IgG4-RD criteria; the two diseases could be present simultaneously or metachronously during the patients' medical history. AAV was defined by the American College of Rheumatology 1990

Patient characteristics

Eighteen patients were included, with an age ranging from 32 to 84 years (median 55.5 years), and a male/female ratio of 2.6. AAV and IgG4-RD were mainly diagnosed concomitantly in 13/18 (72%) patients, AAV preceded IgG4-RD in 3/18 (17%), and IgG4-RD was diagnosed before AAV in 2/18 (11%).

Discussion

We conducted a European multicenter study to investigate the potential overlap between AAV and IgG4-RD. We identified some patients presenting with clinical and/or histological evidence of both diseases, consistent with overlap syndrome given current classification criteria and raising the question of pathophysiological similarities and potential therapeutic strategies that could target both conditions.

In the present study, we observed that AAV and IgG4-RD overlap syndrome concerned mainly GPA

Funding support

None.

Disclosure statement

Authors have not conflicts of interest.

References (47)

  • C.B. Carrington et al.

    Limited forms of angiitis and granulomatosis of Wegener's type

    Am J Med

    (1966)
  • S.Y. Chang et al.

    IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener's): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases

    Hum Pathol

    (2013)
  • J.C. Jennette et al.

    2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    Arthritis Rheum

    (2013)
  • B.M. Córdova-Sánchez et al.

    Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement

    Clin Rheumatol

    (2016)
  • J.U. Holle et al.

    Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

    Ann Rheum Dis

    (2010)
  • G. De Luna et al.

    Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes

    Rheumatol Oxf Engl

    (2015)
  • J.H. Stone et al.

    IgG4-related disease

    N Engl J Med

    (2012)
  • T. Kamisawa et al.

    A new clinicopathological entity of IgG4-related autoimmune disease

    J Gastroenterol

    (2003)
  • M. Dahlgren et al.

    Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum

    Arthritis Care Res

    (2010)
  • J.R. Stone

    Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease

    Curr Opin Rheumatol

    (2011)
  • V. Deshpande et al.

    Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease

    Am J Surg Pathol

    (2011)
  • Y. Raissian et al.

    Diagnosis of IgG4-related tubulointerstitial nephritis

    J Am Soc Nephrol

    (2011)
  • R. Perez Alamino et al.

    IgG4-associated vasculitis

    Curr Rheumatol Rep

    (2013)
  • M. Ebbo et al.

    Pathologies associated with serum IgG4 elevation

    Int J Rheumatol

    (2012)
  • J.A. Ferry et al.

    IgG4-related orbital disease and its mimics in a Western population

    Am J Surg Pathol

    (2015)
  • D.A. Bloch et al.

    The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods

    Arthritis Rheum

    (1990)
  • R. Watts et al.

    Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

    Ann Rheum Dis

    (2007)
  • H. Umehara et al.

    Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

    Mod Rheumatol Jpn Rheum Assoc

    (2012)
  • M. Ebbo et al.

    IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry

    Medicine (Baltimore)

    (2012)
  • A. Vaglio et al.

    Chronic periaortitis: a large-vessel vasculitis?

    Curr Opin Rheumatol

    (2011)
  • A. Vaglio et al.

    Idiopathic retroperitoneal fibrosis

    J Am Soc Nephrol

    (2016)
  • J.H. Stone et al.

    Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial

    Arthritis Rheum

    (2003)
  • R.A. Luqmani et al.

    Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis

    QJM

    (1994)
  • Cited by (0)

    View full text